Real-time enrollment status for this currently only enrolling glioblastoma patients at first recurrence clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 7:21 PM UTC
| NCT Number | NCT05139056 |
| Recruiting Status | Recruiting |
| Condition | Currently Only Enrolling Glioblastoma Patients at First Recurrence |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 4 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 17, 2026: Clinical trial NCT05139056 is currently recruiting participants. This phase1 study for currently only enrolling glioblastoma patients at first recurrence is actively seeking new participants at 4 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05139056 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05139056 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.